Laminin-5 as a marker of invasiveness in cervical lesions

Journal of the National Cancer Institute

Volumn 91, Issue 21, 1999, Pages 1882-1887

  Skyldberg, Barbro ^a,b   Salo, Sirpa ^c   Eriksson, Elina ^c   Aspenblad, Ulla ^c   Moberger, Birgitta ^c   Tryggvason, Karl ^c   Auer, Gert ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Karolinska Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CYCLIN A; KALININ; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; POLYCLONAL ANTIBODY;

ARTICLE; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; PLEURA METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA;

EID: 0033520765     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.21.1882     Document Type: Article

References (40)

1. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993; 55:891-903.
2. Cancer incidence in Sweden 1996. Socialstyrelsen, Epidemiologiskt centrum; The National Board of Health and Welfare. Centre for Epidemiology. Stockholm (Sweden): Socialstyrelsen; 1998.
3. Gissmann L. Papillomaviruses and their association with cancer in animals and in man. Cancer Surv 1984;3:161-81.
4. Pecoraro G, Lee M, Morgan D, Defendi V. Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells. Am J Pathol 1991;138:1-8.
5. Anderson MC. Premalignant and malignant disease of the cervix. In: Haines M, editor. Obstetrical and gynaecological pathology. 3rd ed. London (U.K.): Churchill Livingstone; 1987. p. 255-301.
6. Richart RM. Cervical intraepithelial neoplasia. Pathol Annu 1973;8:301-28.
7. Petersen O. Spontaneous course of cervical precancerous conditions. Am J Obstet Gynecol 1956;72: 1063-71.
8. Gustafsson L, Adami HO. Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer 1989;60:132-41.
9. Burgeson R, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H, et al. A new nomenclature for the laminins. Matrix Biol 1994;14:209-11.
10. Engvall E, Wewer UM. Domains of laminin. J Cell Biochem 1996;61:493-501.
11. Miner JH, Patton BL, Lentz, SI, Gilbert DJ, Snider WD, Jenkins NA, et al. The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha 1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform. J Cell Biol 1997;137:685-701.
12. livanainen A, Morita T, Tryggvason K. Molecular cloning and tissue-specific expression of a novel murine laminin g3 chain. J Biol Chem 1999;274:14107-11.
13. Marinkovich MP, Lunstrum GP, Keene DR, Burgeson RE. The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol 1992;119:695-703.
14. Ryan MC, Tizard R, VanDevanter DR, Carter WG. Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair. J Biol Chem 1994; 269:22779-87.
15. Gerecke DR, Wagman DW, Champliaud MF, Burgeson RE. The complete primary structure for a novel laminin chain, the laminin B1k chain. J Biol Chem 1994;269:11073-80.
16. Kallunki P, Sainio K, Eddy R, Byers M, Kallunki T, Sariola H, et al. A truncated laminin chain homologous to the B2 chain: structure spatial expression, and chromosomal assignment. J Cell Biol 1992;119:679-93.
17. Verrando P, Hsi BL, Yeh CJ, Pisani A, Serieys N, Ortonne JP. Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. Exp Cell Res 1987;170:116-28.
18. Carter WG, Ryan MC, Gahr PJ. Epiligrin, a new cell adhesion ligand for integrin α3β1 in epithelial basement membranes. Cell 1991;65: 599-610.
19. Rousselle P, Lunstrum GP, Keene DR, Burgeson RE. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol 1991;114:567-76.
20. Miyazaki K, Kikkawa Y, Nakamura A, Yasumitsu H, Umeda M. A large cell-adhesive scatter factor secreted by human gastric carcinoma cells. Proc Natl Acad Sci U S A 1993; 90:11767-71.
21. Marinkovich MP, Verrando P, Keene DR, Meneguzzi G, Lunstrum GP, Ortonne JP, et al. Basement membrane proteins kalinin and nicein are structurally and immunologically identical. Lab Invest 1993;69:295-9.
22. Mizushima H, Miyagi Y, Kikkawa Y, Yamanaka N, Yasumitsu H, Misugi K, et al. Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors. J Biochem (Tokyo) 1996;120: 1196-202.
23. Pyke C, Romer J, Kallunki P, Lund LR, Ralfkiaer E, Dano K, et al. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 1994;145:782-91.
24. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995;55:4132-9.
25. Soini Y, Maatta M, Salo S, Tryggvason K, Autio-Harmainen H. Expression of the laminin gamma 2 chain in pancreatic adenocarcinoma. J Pathol 1996;180:290-4.
26. Kainulainen T, Autio-Harmainen H, Oikarinen A, Salo S, Tryggvason K, Salo T. Altered distribution and synthesis of laminin-5 (kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas. Br J Dermatol 1997;136:331-6.
27. Sordat I, Bosman FT, Dorta G, Rousselle P, Aberdam D, Blum AL, et al. Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia. J Pathol 1998;185:44-52.
28. Hao J, Yang Y, McDaniel KM, Dalkin BL, Cress AE, Nagle RB. Differential expression of laminin 5 (α3β3-γ2) by human malignant and normal prostate. Am J Pathol 1996;149:1341-9.
29. Larjava H, Salo T, Haapasalmi K, Kramer RH, Heino J. Expression of integrins and basement membrane components by wound keratinocytes. Clin Invest 1993;92:1425-35.
30. Rousselle P, Aumailley M. Kalinin is more efficient than laminin in promoting adhesion of primary keratinocytes and some other epithelial cells and has a different requirement for integrin receptors. J Cell Biol 1994;125:205-14.
31. Niessen CM, Hogervorst F, Jaspars LH, de Melker AA, Delwel GO, Hulsman EH, et al. The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin. Exp Cell Res 1994; 211:360-7.
32. Orian-Rousseau V, Aberdam D, Rousselle P, Messent A, Gavrilovic J, Meneguzzi G, et al. Human colonic cancer cells synthesize and adhere to laminin-5. Their adhesion to laminin-5 involves multiple receptors among which is integrin alpha2beta1. J Cell Sci 1998;111(Pt 14): 1993-2004.
33. Annual report gynecological cancer F.I.G.O. Vol. 20. Stockholm (Sweden); 1988.
34. Salo S, Haakana H, Kontusaari S, Hujanen E, Kallunki T, Tryggvason K. Laminin-5 promotes adhesion and migration of epithelial cells: identification of migration-related element in the gamma2 chain gene (LAMC2) with activity in transgenic mice. Matrix Biol 1999; 18:197-210.
35. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955;11: 375-86.
36. Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Dano K. The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res 1991;51:4067-71.
37. Tani T, Karttunen T, Kiviluoto T, Kivilaakso E, Burgeson RE, Sipponen P, et al. Alpha 6 beta 4 integrin and newly deposited laminin-1 and laminin-5 form the adhesion mechanism of gastric carcinoma. Continuous expression of laminins but not that of collagen VII is preserved in invasive parts of the carcinomas: implications for acquisition of the invading phenotype. Am J Pathol 1996;149:781-93.
38. Kottmeier HL. Evolution et traitement des epi theliomas. Rev Fr Gynecol Obstet 1961;56: 821.
39. Pettersson F. Secondary prevention screening for carcinoma of the cervix. In: Kavanagh JJ, Singletary SE, Einhorn N, DePetrillo AD, editors. Cancer in women. Cambridge (MA); Oxford (U.K.): Blackwell Science, Inc.; 1998. p. 240-50.
40. Morrison BJ, Coldman AJ, Boyes DA, Anderson GH. Forty years of repeated screening: the significance of carcinoma in situ. Br J Cancer 1996;74:814-9.